Newsroom

Story

On the World Day for Laboratory Animals April 24, 2023, special attention is paid to the use of animals for research and development of products for humans. In drug research, among other areas, extensive animal testing is a firmly prescribed part of the approval process for new drugs. However, a reduction in the number of laboratory animals is increasingly in sight due to new approaches. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), a site of the Helmholtz Centre for Infection Research (HZI) in collaboration with Saarland University, researchers are successfully developing alternative models and have already received awards for their work.

24.04.2023

HIPS

News

Dr Yannic Bartsch's TWINCORE junior research group "Antiviral Antibody Omics" is being funded as a Helmholtz Young Investigator Group (HYIG). Over the next five years, the immunologist will receive a total of 1.5 million euros, half of which will be funded by the Helmholtz Association and half by the Helmholtz Centre for Infection Research (HZI) in Braunschweig. Bartsch already began his work at TWINCORE in January. He is researching the role of antibody responses in infections.

01.04.2023

TWINCORE

News

The COVID-19 pandemic has dramatically demonstrated that the development of effective agents against viral pathogens is of great importance for global health. Although effective vaccines are available for many viral diseases, there is an urgent need for new and effective therapeutic treatments. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), the team led by Prof Rolf Müller is researching novel active substances for the treatment of infections. In their latest studies, the researchers were able to identify two new natural product families with promising activity against viruses. Their results have now been published in the journal Angewandte Chemie International Edition.

20.03.2023

HZI Campus

TWINCORE

HIPS

News

Infection with SARS-CoV-2 leads to severe disease in some people, whereas others do not get ill or only experience mild disease. What causes these differences is not fully understood. It is already known that an overactive innate immune system is causing severe COVID-19 disease, but it is unclear how this is regulated. A team led by Prof Yang Li, Director at the Centre for Individualised Infection Medicine (CiiM) and head of department “Computational Biology for Individualised Medicine” at the Helmholtz Centre for Infection Research (HZI), has come a step closer to answering this question. The researchers addressed the question to what extent the course of disease is genetically or epigenetically regulated. The CiiM is a joint initiative by the HZI and Hannover Medical School (MHH). In addition to Li, the team included other scientists from the HZI and the RESIST cluster of excellence.

23.02.2023

HZI Campus

CiiM

HIRI

News

22.02.2023

HZI Campus

TWINCORE

CRC

Fluorescence microscopic image of a zebrafish larva in which neutrophil granulocytes

News

In the ImageTox project, the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) and the CISPA Helmholtz Center for Information Security are pooling their expertise in the fields of drug discovery and artificial intelligence (AI). Using state-of-the-art machine learning methods, the two Saarbrücken institutes aim to make research into the modes of action of new drugs more efficient. The project is an initiative within the Helmholtz Medical Security, Privacy, and AI Research Center (HMSP), which brings together leading experts from the fields of IT security, data privacy and AI, and medicine to solve pressing medical challenges. ImageTox is funded with 200,000 euros from Helmholtz Imaging, an initiative to promote imaging research.

15.02.2023

HIPS

Back to the first page
...
36
37
38
39
...
149

HZI in the media

... “, sagte die Leiterin der Epidemiologie am Braunschweiger Helmholtz-Zentrum für Infektionsforschung.

Lange betonte, flächendeckende ...

28.11.2025

Evangelische Zeitung

... ein Zentrum für Quantentechnologie entstehen und das Helmholtz-Institut für Pharmazeutische Forschung ausgebaut werden.

Mehr ...

27.11.2025

Tagesschau

Euro werden investiert in die Erweiterung des Helmholtz-Instituts für Pharmazeutische Forschung Saarland (HIPS). Und ...

27.11.2025

ZEIT online

s drug tolcapone. HIPS is a site of the Helmholtz Center for Infection Research (HZI) in collaboration with Saarland University.

The

26.11.2025

Medical Xpress

... erhielt das Projekt „Citrapeutics“ vom Helmholtz-Zentrum für Infektionsforschung (HZI) in Braunschweig eine Förderung in Höhe ...

25.11.2025

Bionity.COM

led by Hannover Medical School (MHH) and the Helmholtz Center for Infection Research (HZI) has now discovered clear molecular signatures for

24.11.2025

Medical Xpress

Medizinischen Hochschule Hannover (MHH) und dem Helmholtz-Zentrum für Infektionsforschung (HZI), hat nun eindeutige molekulare Signaturen ...

24.11.2025

DeutschesGesundheitsPortal

Braunschweig. Das Helmholtz-Zentrum für Infektionsforschung (HZI) bringt anlässlich seines 60. Jubiläums seine Forschung vom 3. ...

22.11.2025

Regional Heute

Universität Hannover (LUH), dem Helmholtz Zentrum für Infektionsforschung (HZI) in Braunschweig, der Technischen Universität Braunschweig ...

21.11.2025

Medizinische Hochschule Hannover

... 38100 Braunschweig Das Helmholtz-Zentrum für Infektionsforschung: Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung ( ...

20.11.2025

Bochumer-Zeitung

Dr. Dunja Bruder ist Forschungsgruppenleiterin am Helmholtz-Zentrum für Infektionsforschung in Braunschweig und zugleich Professorin für

20.11.2025

Bilanz

... Wissenschaftler und Wissenschaftlerinnen des Helmholtz-Zentrums für Infektionsforschung (HZI) und der Medizinischen Hochschule ...

19.11.2025

Rheinische Post

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.